HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today announced that data from the ARC-20 study will be presented in a rapid oral session at the 2025 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium taking place February 13 – 15, 2025, in San Francisco, CA. The oral presentation will highligh
More in Trade Show
Trade Show
Consensus Cloud Solutions to Demonstrate How AI-Powered Fax Solutions Bridge Healthcare's Digital Divide at ViVE 2025
LOS ANGELES–(BUSINESS WIRE)–Consensus Cloud Solutions, Inc. (NASDAQ: CCSI), a leading provider of digital ...
Trade Show
Ocean Spray® Ingredients to Showcase On-Trend Ingredients & Flavors at Gulfood 2025 Exposition
–(BUSINESS WIRE)–Ocean Spray® Ingredients: WHAT Ocean Spray® Ingredients will be at Gulfood’s 30th ...
Trade Show
Bayer Unveils Latest Data from Prostate Cancer Portfolio at 2025 ASCO GU Cancers Symposium
WHIPPANY, N.J.–(BUSINESS WIRE)–Bayer Unveils Latest Data from Prostate Cancer Portfolio at 2025 ASCO ...
